{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:10:41Z","timestamp":1791832241702,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000269","name":"RCUK | Economic and Social Research Council","doi-asserted-by":"publisher","award":["ES\/T00908X\/1"],"award-info":[{"award-number":["ES\/T00908X\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-invasive prenatal testing (NIPT) has been available commercially in Europe since approximately 2012. Currently, many countries are in the process of integrating NIPT into their publicly funded healthcare systems to screen for chromosomal aneuploidies such as trisomy 21\u00a0(Down syndrome), with a variety of implementation models. In 2019, the German Federal Joint Committee (G-BA), which plays a significant role in overseeing healthcare decisions\u00a0in Germany, recommended that NIPT be reimbursed through public insurance. Following this recommendation, NIPT will be offered on a case-by-case basis, when a pregnant woman, after being counselled, makes an informed decision that the test is necessary in her personal situation. This model differs significantly from many other European countries, where NIPT is being implemented either as a first-tier screening offer available for all pregnancies, or a contingent screen for those with a high probability of foetal aneuploidy (with varying probability cut-offs). In this paper we examine how this unique approach to implementing NIPT\u00a0in Germany is produced by an ethical and policy landscape resulting from a distinctive cultural and historical context with a significant influence on healthcare decision-making. Due in part to the specific legal and regulatory environment, as well as strong objections from various stakeholders, Germany did not implement NIPT as a first-tier screen. However, as Germany does not currently publicly fund as standard\u00a0other forms of prenatal\u00a0aneuploidy screening (such as combined first trimester screening), neither can it be implemented as a screen contingent on specific probability cut-offs. We discuss how German policy reflects the echoes of the past shaping approaches to new biotechnologies, and the implications of this unique model for\u00a0implementing NIPT in a public healthcare system.<\/jats:p>","DOI":"10.1038\/s41431-022-01256-x","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T06:02:59Z","timestamp":1670824979000},"page":"562-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Non-invasive prenatal testing in Germany: a unique ethical and policy landscape"],"prefix":"10.1038","volume":"31","author":[{"given":"Hilary","family":"Bowman-Smart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8260-0346","authenticated-orcid":false,"given":"Claudia","family":"Wiesemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5714-3905","authenticated-orcid":false,"given":"Ruth","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"1256_CR1","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.3390\/diagnostics12112816","volume":"12","author":"T Liehr","year":"2022","unstructured":"Liehr T, Harutyunyan T, Williams H, Weise A. Non-invasive prenatal testing in Germany. Diagnostics. 2022;12:2816.","journal-title":"Diagnostics."},{"key":"1256_CR2","doi-asserted-by":"publisher","first-page":"e81794","DOI":"10.1371\/journal.pone.0081794","volume":"8","author":"H Yi","year":"2013","unstructured":"Yi H, Hallowell N, Griffiths S, Yeung, Leung T. Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong. PLoS One. 2013;8:e81794.","journal-title":"PLoS One"},{"key":"1256_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-genom-083118-015053","volume":"22","author":"V Ravitsky","year":"2021","unstructured":"Ravitsky V, Roy MC, Haidar H, Henneman L, Marshall J, Newson AJ, et al. The emergence and global spread of noninvasive prenatal testing. Annu Rev Genom Hum Genet. 2021;22:309\u201338.","journal-title":"Annu Rev Genom Hum Genet"},{"key":"1256_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-med-072115-033220","volume":"68","author":"L Hui","year":"2017","unstructured":"Hui L, Bianchi DW. Noninvasive prenatal DNA testing: the vanguard of genomic medicine. Annu Rev Med. 2017;68:459\u201372.","journal-title":"Annu Rev Med"},{"key":"1256_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1136\/medethics-2019-105885","volume":"46","author":"D Schmitz","year":"2020","unstructured":"Schmitz D. Why public funding for non-invasive prenatal testing (NIPT) might still be wrong: a response to Bunnik and colleagues. J Med Ethics. 2020;46:781\u20132.","journal-title":"J Med Ethics"},{"key":"1256_CR6","unstructured":"Public Health England. Fetal anomaly screening programe handbook: guidance overview [Internet]. GOV.UK. 2021. https:\/\/www.gov.uk\/government\/publications\/fetal-anomaly-screening-programme-handbook\/overview. Accessed 6 Apr 2022."},{"key":"1256_CR7","doi-asserted-by":"crossref","unstructured":"Horn R NIPT and the concerns regarding \u2018routinisation.\u2019 Eur J Hum Genet. 2022;30:637\u2013638","DOI":"10.1038\/s41431-022-01053-6"},{"key":"1256_CR8","unstructured":"Aufgabe und Arbeitsweise - Gemeinsamer Bundesausschuss [Internet]. https:\/\/www.g-ba.de\/ueber-den-gba\/aufgabe-arbeitsweise\/. Accessed 1 Sept 2022."},{"key":"1256_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/14636778.2020.1805305","volume":"40","author":"S Reinsch","year":"2021","unstructured":"Reinsch S, K\u00f6nig A, Rehmann-Sutter C. Decision-making about non-invasive prenatal testing: women\u2019s moral reasoning in the absence of a risk of miscarriage in Germany. N Genet Soc. 2021;40:199\u2013215.","journal-title":"N Genet Soc"},{"key":"1256_CR10","unstructured":"Gemeinsamer Bundesausschuss. Mutterschafts-Richtlinien (Mu-RL) [Internet]. 2022. https:\/\/www.g-ba.de\/downloads\/62-492-2676\/Mu-RL_2021-09-16_iK-2022-01-01.pdf. Accessed 17 May 2022."},{"key":"1256_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.12717\/DR.2021.25.2.113","volume":"25","author":"NK Kim","year":"2021","unstructured":"Kim NK. A normative review on non-invasive prenatal diagnosis (NIPD): focusing on the German Discussion on PrenaTest\u00ae. Dev Reprod. 2021;25:113\u201321.","journal-title":"Dev Reprod"},{"key":"1256_CR12","unstructured":"Feyerabend E, Huster-Sinemillioglu A. Genanalysen in der Schwangerenvorsorge: Keine Zeit zum Nachdenken [Internet]. Deutsches \u00c4rzteblatt. 2014. https:\/\/www.aerzteblatt.de\/archiv\/162880\/Genanalysen-in-der-Schwangerenvorsorge-Keine-Zeit-zum-Nachdenken Accessed 2 Mar 2022."},{"key":"1256_CR13","unstructured":"Kolleck A, Sauter A. Aktueller Stand und Entwicklungen der Pr\u00e4nataldiagnostik: Endbericht zum Monitoring [Internet]. B\u00fcro f\u00fcr Technikfolgen-Absch\u00e4tzung beim Deutschen Bundestag; 2019. https:\/\/publikationen.bibliothek.kit.edu\/1000102614."},{"key":"1256_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/14636778.2018.1495555","volume":"37","author":"K Braun","year":"2018","unstructured":"Braun K, K\u00f6nninger S. Realizing responsibility. Institutional routines, critical intervention, and the \u2018big\u2019 questions in the controversy over non-invasive prenatal testing in Germany. N Genet Soc. 2018;37:248\u201367.","journal-title":"N Genet Soc"},{"key":"1256_CR15","unstructured":"Deutschen Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe e.V.,. Stellungnahme: NIPT [Internet]. 2019. https:\/\/www.dggg.de\/fileadmin\/data\/Stellungnahmen\/GBCOG\/2019\/290419_4._Stellungnahme_GBCOG_NIPT.pdf"},{"key":"1256_CR16","unstructured":"Renner I Schwangerschaftserleben und Pr\u00e4nataldiagnostik: Repr\u00e4sentative Befragung Schwangerer zum Thema Pr\u00e4nataldiagnostik 2006 [Internet]. Bundeszentrale f\u00fcr gesundheitliche Aufkl\u00e4rung (BZgA); 2006. https:\/\/shop.bzga.de\/schwangerschaftserleben-und-praenataldiagnostik-13319200\/. Accessed 4 Apr 2022."},{"key":"1256_CR17","unstructured":"Sch\u00e4fers R, Kolip P Zusatzangebote in der Schwangerschaft: Sichere Rundum-versorgung oder Gesch\u00e4ft mit der Unsicherheit? Gesundheitsmonitor [Internet]. 2015; https:\/\/www.bertelsmann-stiftung.de\/fileadmin\/files\/Projekte\/17_Gesundheitsmonitor\/Newsletter_Ueberversorgung_in_der_Schwangerschaft_20150727.pdf"},{"key":"1256_CR18","doi-asserted-by":"crossref","unstructured":"van der Meij KRM, de Groot\u2010van Mooren M, Carbo EWS, Pieters MJ, Rodenburg W, Sistermans EA, et al. Uptake of fetal aneuploidy screening after the introduction of the non\u2010invasive prenatal test: a national population\u2010based register study. Acta Obstet Gynecol Scand. 2021;100:1265\u20131272.","DOI":"10.1111\/aogs.14091"},{"key":"1256_CR19","unstructured":"Bundesministerium der Justiz,. Gendiagnostikgesetz - GenDG, \u00a7 15 Vorgeburtliche genetische Untersuchungen [Internet]. 2010. https:\/\/www.gesetze-im-internet.de\/gendg\/__15.html"},{"key":"1256_CR20","unstructured":"Bundesministerium der Justiz,. Schwangerschaftskonfliktgesetz - SchKG [Internet]. 2022. https:\/\/www.gesetze-im-internet.de\/beratungsg\/BJNR113980992.html"},{"key":"1256_CR21","unstructured":"Bundesministerium der Justiz,. Strafgesetzbuch (StGB): \u00a7 218 Schwangerschaftsabbruch [Internet]. 1992. https:\/\/www.gesetze-im-internet.de\/stgb\/__218.html"},{"key":"1256_CR22","unstructured":"Kommission f\u00fcr \u00d6ffentlichkeitsarbeit und ethische Fragen der Gesellschaft f\u00fcr Humangenetik e.V. Stellungnahme zur Neufassung des \u00a7 218a StGB mit Wegfall der sogenannten embryopathischen Indikation zum Schwangerschaftsabbruch [Internet]. 2001. https:\/\/gfhev.de\/de\/veroeffentlichungen\/s-1995_Stellungnahme_zur_Neufassung_218-StGB.PDF. Accessed 20 Apr 2022."},{"key":"1256_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/lawfam\/11.1.36","volume":"11","author":"CP Schlegel","year":"1997","unstructured":"Schlegel CP. Landmark in German abortion Law: The German 1995 Compromise Compared with English Law. Int J Law Policy Fam 1997;11:36\u201362.","journal-title":"Int J Law Policy Fam"},{"issue":"4","key":"1256_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/jme.2002.002634","volume":"30","author":"S Edwards","year":"2004","unstructured":"Edwards S. Disability, identity and the \u2018expressivist objection. J Med Ethics. 2004;30(4):418\u201320.","journal-title":"J Med Ethics"},{"issue":"7","key":"1256_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/bioe.12365","volume":"31","author":"B Hofmann","year":"2017","unstructured":"Hofmann B. \u2018You are inferior!\u2019 Revisiting the expressivist argument. Bioethics. 2017;31(7):505\u201314.","journal-title":"Bioethics."},{"key":"1256_CR26","doi-asserted-by":"publisher","unstructured":"Kaposy C. An expressivist disability critique of the expansion of prenatal genomics. In: Allyse MA, Michie M, editors. Born well: prenatal genetics and the future of having children [Internet]. Cham: Springer International Publishing; 2022. p. 57\u201377. (The International Library of Bioethics). https:\/\/doi.org\/10.1007\/978-3-030-82536-2_5. Accessed 21 April 2022.","DOI":"10.1007\/978-3-030-82536-2_5"},{"key":"1256_CR27","unstructured":"Bundesministerium der Justiz,. Sozialgesetzbuch (SGB) F\u00fcnftes Buch (V) - Gesetzliche Krankenversicherung [Internet]. 1989. https:\/\/www.gesetze-im-internet.de\/sgb_5\/__2.html"},{"key":"1256_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/bioe.12880","volume":"35","author":"H Foth","year":"2021","unstructured":"Foth H. Avoiding \u2018selection\u2019?\u2014References to history in current German policy debates about non-invasive prenatal testing. Bioethics. 2021;35:518\u201327.","journal-title":"Bioethics."},{"issue":"Oct","key":"1256_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1515\/jpm-2021-0204","volume":"49","author":"K Zerres","year":"2021","unstructured":"Zerres K, Rudnik-Sch\u00f6neborn S, Holzgreve W. Do non-invasive prenatal tests promote discrimination against people with Down syndrome? What should be done? J Perinat Med. 2021;49:965\u201371.","journal-title":"J Perinat Med"},{"key":"1256_CR30","unstructured":"Deutscher Ethikrat. Die Zukunft der genetischen Diagnostik\u2014von der Forschung in die klinische Anwendung [Internet]. 2013. https:\/\/www.ethikrat.org\/fileadmin\/Publikationen\/Stellungnahmen\/deutsch\/stellungnahme-zukunft-der-genetischen-diagnostik.pdf."},{"key":"1256_CR31","unstructured":"Decker E. PraenaTest\u00ae jetzt in Deutschland, \u00d6sterreich, Liechtenstein und in der Schweiz verf\u00fcgbar [Internet]. PraenaTest. 2012. https:\/\/lifecodexx.com\/praenatest-jetzt-in-deutschland-oesterreich-liechtenstein-und-in-der-schweiz-verfuegbar\/. Accessed 6 Apr 2022."},{"key":"1256_CR32","unstructured":"Henn W, Schmitz D. Pr\u00e4nataldiagnostik: Paradigmenwechsel [Internet]. Deutsches \u00c4rzteblatt. 2012. https:\/\/www.aerzteblatt.de\/archiv\/127076\/Praenataldiagnostik-Paradigmenwechsel. Accessed 6 Apr 2022."},{"issue":"Suppl 3","key":"1256_CR33","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1002\/hast.793","volume":"47","author":"V Ravitsky","year":"2017","unstructured":"Ravitsky V. The shifting landscape of prenatal testing: between reproductive autonomy and public health. Hastings Cent Rep. 2017;47:S34\u201340.","journal-title":"Hastings Cent Rep"},{"key":"1256_CR34","first-page":"42","volume":"35","author":"K Braun","year":"2005","unstructured":"Braun K. Not just for experts: the public debate about reprogenetics in Germany. Hastings Cent Rep. 2005;35:42\u20139.","journal-title":"Hastings Cent Rep"},{"key":"1256_CR35","doi-asserted-by":"crossref","unstructured":"Perrot A, Horn R. The ethical landscape(s) of non-invasive prenatal testing in England, France and Germany: findings from a comparative literature review. Eur J Hum Genet. 2022;30:676\u2013681.","DOI":"10.1038\/s41431-021-00970-2"},{"key":"1256_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/medethics-2017-104729","volume":"44","author":"A Kater-Kuipers","year":"2018","unstructured":"Kater-Kuipers A, Beaufort ID, de, Galjaard RJH, Bunnik EM. Ethics of routine: a critical analysis of the concept of \u2018routinisation\u2019 in prenatal screening. J Med Ethics. 2018;44:626\u201331.","journal-title":"J Med Ethics"},{"issue":"Sep","key":"1256_CR37","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3390\/jpm11090937","volume":"11","author":"M Orzechowski","year":"2021","unstructured":"Orzechowski M, Timmermann C, Woniak K, Kosenko O, Mikirtichan GL, Lichtshangof AZ, et al. Access to prenatal testing and ethically informed counselling in Germany, Poland and Russia. J Pers Med. 2021;11:937.","journal-title":"J Pers Med"},{"key":"1256_CR38","doi-asserted-by":"crossref","unstructured":"Raz AE, Nov-Klaiman T, Hashiloni-Dolev Y, Foth H, Sch\u00fces C, Rehmann-Sutter C Comparing Germany and Israel regarding debates on policy-making at the beginning of life: PGD, NIPT and their paths of routinization. Ethik Med. 2022;34:65\u201380.","DOI":"10.1007\/s00481-021-00652-z"},{"key":"1256_CR39","unstructured":"SchKG - Gesetz zur Vermeidung und Bew\u00e4ltigung von Schwangerschaftskonflikten [Internet]. 1992. https:\/\/www.gesetze-im-internet.de\/beratungsg\/BJNR113980992.html"},{"key":"1256_CR40","unstructured":"Strafgesetzbuch \u00a7 219 - Beratung der Schwangeren in einer Not- und Konfliktlage [Internet]. https:\/\/www.gesetze-im-internet.de\/stgb\/__219.html"},{"key":"1256_CR41","unstructured":"Schmidtke J. Public Health Genetics: In Deutschland noch umstritten [Internet]. Deutsches \u00c4rzteblatt. 2007. https:\/\/www.aerzteblatt.de\/archiv\/57226\/Public-Health-Genetics-In-Deutschland-noch-umstritten. Accessed 20 Apr 2022."},{"key":"1256_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00103-014-2088-z","volume":"58","author":"HG Klein","year":"2015","unstructured":"Klein HG, Rost I. Moderne genetische Analysemethoden. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2015;58:113\u201320.","journal-title":"Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"},{"key":"1256_CR43","unstructured":"Sander T. Offener Brief: Gemeinsamer Bundesausschuss, Prof. Josef Hecken [Internet]. 2021. https:\/\/www.lebenshilfe.de\/fileadmin\/Redaktion\/PDF\/Wissen\/public\/Gemeinsame-Stellungnahmen\/21-02-05_Offener_Brief_G-BA_Logo_Druck.pdf"},{"key":"1256_CR44","unstructured":"Gemeinsamer Bundesausschuss. Antworten auf h\u00e4ufig gestellte Fragen zum NIPT auf Trisomien [Internet]. https:\/\/www.g-ba.de\/themen\/methodenbewertung\/ambulant\/frueherkennung-krankheiten\/erwachsene\/schwangerschaft-mutterschaft\/faqs-nipt\/. Accessed 17 May 2022."},{"key":"1256_CR45","unstructured":"Gemeinsamer Bundesausschuss. Beratungsverfahren Methodenbewertung Mutterschafts-Richtlinien (Mu-RL): Nicht-invasive Pr\u00e4nataldiagnostik zur Bestimmung des Risikos autosomaler Trisomien 13, 18 und 21 mittels eines molekulargenetischen Tests (NIPT-Trisomie 13,18,21) f\u00fcr die Anwendung bei Schwangerschaften mit besonderen Risiken [Internet]. 2021. https:\/\/www.g-ba.de\/downloads\/40-268-7786\/2021-08-19_Mu-RL_NIPT_Versicherteninformation_ZD.pdf."},{"key":"1256_CR46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/jpc.13494_132","volume":"53","author":"L Hui","year":"2017","unstructured":"Hui L, Hutchinson B, Poulton A, Halliday J. State-wide impact of noninvasive prenatal testing (NIPT) on fetal aneuploidy screening and diagnosis in Victoria. J Paediatr Child Health. 2017;53:46\u201346.","journal-title":"J Paediatr Child Health"},{"key":"1256_CR47","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00404-015-3674-5","volume":"292","author":"G Manegold-Brauer","year":"2015","unstructured":"Manegold-Brauer G, Berg C, Fl\u00f6ck A, R\u00fcland A, Gembruch U, Geipel A. Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center. Arch Gynecol Obstet. 2015;292:543\u20138.","journal-title":"Arch Gynecol Obstet"},{"key":"1256_CR48","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG),. IQWiG-Berichte \u2013 Nr. 623: Nicht invasive Pr\u00e4nataldiagnostik (NIPD) zur Bestimmung des Risikos autosomaler Trisomien 13, 18 und 21 bei Risikoschwangerschaften [Internet]. Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG); 2018 Apr. Report No.: S16-06. https:\/\/www.iqwig.de\/download\/s16-06_nicht-invasive-praenataldiagnostik-nipd_abschlussbericht_v1-0.pdf"},{"key":"1256_CR49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0033-1335685","volume":"34","author":"C K\u00e4hler","year":"2013","unstructured":"K\u00e4hler C, Gembruch U, Heling KS, Henrich W, Schramm T. DEGUM. [DEGUM guidelines for amniocentesis and chorionic villus sampling]. Ultraschall Med Stuttg Ger 1980. 2013;34:435\u201340.","journal-title":"Ultraschall Med"},{"key":"1256_CR50","doi-asserted-by":"crossref","unstructured":"Alfirevic Z, Navaratnam K, Mujezinovic F Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2017;(9). https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003252.pub2\/full.","DOI":"10.1002\/14651858.CD003252.pub2"},{"key":"1256_CR51","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/uog.22143","volume":"56","author":"D Di Mascio","year":"2020","unstructured":"Di Mascio D, Khalil A, Rizzo G, Buca D, Liberati M, Martellucci CA, et al. Risk of fetal loss following amniocentesis or chorionic villus sampling in twin pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2020;56:647\u201355.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1256_CR52","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/uog.20353","volume":"54","author":"LJ Salomon","year":"2019","unstructured":"Salomon LJ, Sotiriadis A, Wulff CB, Odibo A, Akolekar R. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol. 2019;54:442\u201351.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1256_CR53","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/uog.20293","volume":"54","author":"J Beta","year":"2019","unstructured":"Beta J, Zhang W, Geris S, Kostiv V, Akolekar R. Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis. Ultrasound Obstet Gynecol. 2019;54:452\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1256_CR54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/1471-0528.14050","volume":"124","author":"FL Mackie","year":"2017","unstructured":"Mackie FL, Hemming K, Allen S, Morris RK, Kilby MD. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. Int J Obstet Gynaecol. 2017;124:32\u201346.","journal-title":"Int J Obstet Gynaecol"},{"key":"1256_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/aogs.13047","volume":"96","author":"E Iwarsson","year":"2017","unstructured":"Iwarsson E, Jacobsson B, Dagerhamn J, Davidson T, Bernab\u00e9 E, Heibert Arnlind M. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population \u2013 a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2017;96:7\u201318.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"Dec","key":"1256_CR56","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1080\/14767058.2018.1481033","volume":"32","author":"KM Chen","year":"2019","unstructured":"Chen KM, White K, Shabbeer J, Schmid M. Maternal age trends support uptake of non-invasive prenatal testing (NIPT) in the low-risk population. J Matern Fetal Neonatal Med. 2019;32(Dec):4039\u201342.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1256_CR57","unstructured":"pro familia Bundesverband. Schwangerschaftsabbruch\u2014Fakten und Hintergr\u00fcnde [Internet]. 2017. https:\/\/www.profamilia.de\/fileadmin\/publikationen\/Fachpublikationen\/Schwangerschaftsabbruch\/Hintergrund-Schwangerschaftsabbruch.pdf. Accessed 17 May 2022."}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01256-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01256-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01256-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T23:08:32Z","timestamp":1683760112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01256-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1256"],"URL":"https:\/\/doi.org\/10.1038\/s41431-022-01256-x","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"25 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}